Press Releases

Acclaro Medical today announced that its award-winning AuraLux™ Fiber Laser for aesthetic skin applications will be showcased at the annual meeting of the American MedSpa Association to be held at the Wynn Las Vegas on April 9-12, 2026. An evolution of Acclaro’s successful UltraClear® 2910 nm fiber laser platform, AuraLux is specifically engineered as a safe, fast and comfortable treatment solution for total skin health™ across all aesthetic practices and patient demographics.

Renowned dermatologists showcase novel treatment protocols, expanded indications, and real-world successes with UltraClear® fiber laser technology

The spotlight will be on Acclaro’s UltraClear® fiber laser technology innovation as leading dermatology specialists present new treatment results during multiple oral presentations and “Fiber Focus Sessions” at the American Academy of Dermatology annual meeting on March 26-31, 2026, taking place in Denver, CO.

Acclaro Medical today announced the launch of its first-ever National 3DMIRACL® Day, a celebration of one of the fastest-growing aesthetic fiber laser treatments in the U.S. Designed as the ultimate “glow up” refresher, 3DMIRACL® is the go-to treatment for the holiday season and the perfect way to kick off the New Year with smooth, radiant skin. Also launching today is a new website dedicated to 3DMIRACL, with more information about the treatment: https://3dmiracl.com/

Acclaro Medical is proud to announce that leading dermatologic laser experts will spotlight UltraClear® 2910 nm cold ablative fiber laser clinical outcomes in a series of 11 podium presentations at the American Society for Dermatologic Surgery Annual Meeting taking place November 13-16, 2025, in Chicago. The presentations will demonstrate how UltraClear redefines treatment standards across a range of indications, from acne and surgical scars to photoaging and lower face and neck imperfections, on all skin types.

Acclaro Medical is celebrating a season of recognition for its groundbreaking UltraClear® 2910 nm cold ablative fiber laser, which has been honored with a trifecta of prestigious awards from some of the most influential media names in beauty and aesthetics. The honors highlight UltraClear’s leadership in innovation, clinical excellence, and consumer appeal.

Acclaro Medical, innovador mundial en tecnologías avanzadas basadas en energía para los mercados estético, oftálmico y quirúrgico, se complace en anunciar que DIGEMID, la autoridad reguladora del país para dispositivos médicos, ha aprobado su destacado sistema láser de fibra UltraClear® de 2910 nm para ser usado en Perú. Este hito regulatorio es un avance importante en la expansión estratégica de Acclaro en Sudamérica y refuerza su compromiso de hacer que las tecnologías de vanguardia para el rejuvenecimiento de la piel sean más accesibles en todo el mundo.

Acclaro Medical, a global innovator in advanced energy-based technologies for aesthetic, ophthalmic and surgical markets, is proud to announce the approval of its flagship UltraClear® 2910 nm fiber laser by Health Canada. This clearance marks a significant expansion for the company and brings one of the industry’s most advanced skin rejuvenation platforms to Canadian provider and patients. Acclaro Medical has also partnered with Xcite Technology, a recognized leader in aesthetic energy-based device distribution, to spearhead commercialization efforts across Canada.

Acclaro Medical today announced the launch of AuraLux™ cold fiber laser, an evolution of its successful 2910 nm laser technology, specifically developed as an exclusive treatment solution for total skin health and timeless youth across all aesthetic practices and patient demographics. AuraLux will be unveiled at The Medical Spa Show to be held at the Wynn Las Vegas on April 10-13, 2025, and hosted by the American MedSpa Association, a leading multi-faceted national organization for the medical spa industry.

Acclaro Medical is proud to announce that its UltraClear® Laser-Coring™ treatment was honored as a 2025 Award Winner for Best Nonsurgical Skin Removal Procedure for Younger-Looking Skin by NewBeauty Magazine. The UltraClear Laser-Coring accolade is based on an evaluation of thousands of editor- and doctor-vetted aesthetic treatments to determine the most game-changing innovations that deliver effective and results-driven solutions for the most popular beauty concerns of the magazine’s readers.

Acclaro Medical, a pioneering medical technology company focused on developing cutting-edge solutions that improve patient care and redefine medical practices, proudly announces the successful completion of its Series B funding round. Led by Accelmed Partners with participation by existing investor 3E Bioventures Capital, the combined funding of $23 million marks a pivotal milestone in the company’s journey to fulfill unmet aesthetic needs through its innovative 2910 nm fiber laser solution and other disruptive technologies. This capital infusion will help Acclaro accelerate the growth of its flagship products, UltraClear® and AuraLux™ and expedite global market expansion while advancing development of new trailblazing products in its pipeline.

Acclaro Medical, a pioneering medical technology company focused on developing cutting-edge solutions that improve patient care and redefine medical practices, officially opened its new corporate headquarters after a ribbon cutting ceremony on October 28, 2024, in Munich, Germany. The new center marks a major milestone for the fast-growing medical device company that innovates laser devices and treatments to greatly improve aesthetic and medical skin conditions.

Acclaro Medical, a pioneering medical technology company focused on developing cutting-edge solutions that improve patient care and redefine medical practices, today announced five speaker presentations featuring its flagship UltraClear® fiber laser at the upcoming American Society for Dermatologic Surgery (ASDS) Annual Meeting being held on October 17-20 2024, in Orlando, Florida.

~ The Global Market for Pigmented Lesion Treatment Is Expected to Reach $3.37 Billion in 2024, and $4.69 Billion by 20291

MellingMedical today announced a new distribution relationship with Acclaro Medical, an emerging leader in energy-based non-invasive, aesthetic medical devices. As a CVE-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), MellingMedical can provide a preferential pathway into the federal health system for medical equipment innovators like Acclaro.

Acclaro Medical, a trailblazer in the aesthetic medical laser sector, is pleased to announce the rebranding of its flagship product, UltraClear^® Cold Fiber Laser. The strategic initiative marks an important milestone in the company’s evolution, signaling a fresh chapter of growth filled with enhanced customer experiences, groundbreaking innovations, and significant market presence.

Acclaro Corporation, a medical technology company that specializes in developing and delivering novel solutions that address the most challenging needs in the medical aesthetics and surgical fields, today announced that four podium talks will be presented at the American Society for Laser Medicine and Surgery (ASLMS) meeting being held in Phoenix, AZ, on April 13-16, 2023. The presentations will showcase clinical findings from single-session skin resurfacing studies using the novel UltraClear 2,910 nm erbium-doped fluoride fiber laser, as well as data demonstrating histologic changes related to UltraClear’s sophisticated pulse characteristics. Additionally, the results of a study evaluating the safety and efficacy of the UltraClear cold ablative fiber laser for the treatment of photoaging in the skin of color will be shared.

Acclaro Medical Corporation, an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, is thrilled to announce it has been honored with the prestigious NewBeauty award for its game-changing “Cold Fiber” technology for resurfacing all skin tones.

Acclaro Corporation, (formerly FA International LP, Boston, Mass.), breaks new ground in medical devices for aesthetics with their revolutionary UltraClear™ system. This disruptive technology features a no downtime, painless treatment to address a full spectrum of skin conditions including pigmentation, enlarged pores, fine lines, wrinkles, scars and acne scars, age spots, sun damage, textural irregularities and general complexion issues. It is safe for all skin types, including darker skin types III – VI.